Select language:  
1800 620 420
Close menu

Month: February 2020

Ken isn’t ruled by his MPN and is optimistic about his future

Seven years after being diagnosed with PV, Ken’s spleen suddenly ruptured.

  • Myeloproliferative neoplasms
Read more
Ken at a Fluro Friday mental health promotion at Phillip Island in 2016 at which he was a speaker.

New classifications of MPN mean better diagnostics and more definitive prognoses

How the MPNs are classified is set to change with eight new classifications based on the underlying mechanisms that drive the mutations.

  • Myeloproliferative neoplasms
  • Research
Read more
Professor Tony Green

European amyloidosis meeting highlighted the need to improve education

Vince learnt of the concerningly low rates of referral for people at risk of amyloidosis.

  • Amyloidosis
Read more
Vince O'Donnell

New amyloidosis drugs and clinical trials update

A new class of drug may soon be available to Australian patients with significant cardiac AL amyloidosis

  • Amyloidosis
  • Clinical trials
Read more
Dr Hasib Sidiqi, right, with one of his “Mayo mentors” and amyloidosis specialist, Dr Morie Gertz, at the American Society of Hematology 2018 annual meeting.

“It’s an ongoing journey you’ve got to manage”

Cath felt “absolute relief” to be diagnosed with amyloidosis because she finally knew what she was dealing with.

  • Amyloidosis
Read more
Cath Armstrong, right, and her eldest daughter, Rebecca.

Number of Australians living with blood cancer to more than double

  • Advocacy and policy
  • Media releases
Read more
Illustration of a mobile phone flashing 'News' on the screen

Government’s commitment to blood cancer

The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.

  • Advocacy and policy
  • Media releases
Read more
Photograph of politician Greg Hunt